FDA issued a Warning Letter to Sun Pharmaceutical Industries Ltd. on 12/17/2015 for a later inspection.
483 Sun Pharmaceutical Industries Jun 2012

483 Sun Pharmaceutical Industries Jun 2012

Mural Gavini FDA, Scott Laufenberg FDA$119.00 - Available Now

FDA investigators audited the Sun Pharmaceutical Industries - Halol, India facility and issued inspectional observations (via FDA 483) on 13 Jun 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Jun 2012
  • Location: Halol, India
  • FEI: 3002809586
Add To Cart